7Sage Information

7Sage Partners is a healthcare-focused buy-side advisory firm serving private equity firms and other strategics pursuing inorganic growth in healthcare and life sciences. We partner with PE and Strategic deal teams across the full acquisition lifecycle from investment thesis development through proprietary deal origination and execution. Most buy-side firms are engaged at outreach and step away when a target is introduced. 7Sage operates differently. The principals who develop your thesis are the same people who identify your targets, initiate outreach, and stay in the process through close. Our work spans four integrated service areas: Acquisition Strategy: Thesis development, segment prioritization, platform formation guidance Proprietary Target Mapping: Research-driven target universe, thorough pre-qualification, prioritized opportunity set Deal Origination & Execution: Strategy-led outreach, relationship development, deal facilitation through close Buy and Build Roadmap: Focused assessment of inorganic growth potential for existing platform assets What sets 7Sage apart is healthcare fluency. Our principals have spent decades inside healthcare and life sciences, not observing it from the outside. That depth changes who takes the call, how conversations go, and how often they produce proprietary deal flow. It drives our 50-70% outreach touch rate against an industry norm of 20-30%. We serve healthcare-focused private equity firms pursuing platform acquisitions and add-on strategies across pharma services, diagnostics, healthcare technology, clinical research, provider services, MedTech, biopharma, and outsourced healthcare services. 7Sage Partners | Tampa, FL | the7sagepartners.com